Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Tanner

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
The Lancet. Neurology|October 18, 2025
Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunitiesE Ray Dorsey, Briana R De Miranda, Sarrah Hussain, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
Parkinsonism & Related Disorders|June 5, 2012
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variantsChaodong Wang, Yanning Cai, Zheng Zheng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 24, 2017
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)Wolfgang Oertel, Karla Eggert, Rajesh Pahwa, et al.
Annals of Neurology|September 25, 2004
Parkinsonian signs and substantia nigra neuron density in decendents elders without PDG Webster Ross, Helen Petrovitch, Robert D Abbott, et al.
Annals of Neurology|February 21, 2019
Concordance for Parkinson's disease in twins: A 20-year updateSamuel M Goldman, Kenneth Marek, Ruth Ottman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.
Journal of Parkinson'S Disease|May 31, 2024
Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 VariantsEthan G Brown, Samuel M Goldman, Christopher S Coffey, et al.
JMIR Human Factors|May 6, 2022
Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE PlatformEthan G Brown, Erica Schleimer, Ian O Bledsoe, et al.
NPJ Parkinson'S Disease|July 16, 2020
Current and projected future economic burden of Parkinson's disease in the U.SWenya Yang, Jamie L Hamilton, Catherine Kopil, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
The Lancet. Neurology|October 18, 2025
Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunitiesE Ray Dorsey, Briana R De Miranda, Sarrah Hussain, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
Parkinsonism & Related Disorders|June 5, 2012
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variantsChaodong Wang, Yanning Cai, Zheng Zheng, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 24, 2017
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)Wolfgang Oertel, Karla Eggert, Rajesh Pahwa, et al.
Annals of Neurology|September 25, 2004
Parkinsonian signs and substantia nigra neuron density in decendents elders without PDG Webster Ross, Helen Petrovitch, Robert D Abbott, et al.
Annals of Neurology|February 21, 2019
Concordance for Parkinson's disease in twins: A 20-year updateSamuel M Goldman, Kenneth Marek, Ruth Ottman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.
Journal of Parkinson'S Disease|May 31, 2024
Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 VariantsEthan G Brown, Samuel M Goldman, Christopher S Coffey, et al.
JMIR Human Factors|May 6, 2022
Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE PlatformEthan G Brown, Erica Schleimer, Ian O Bledsoe, et al.
NPJ Parkinson'S Disease|July 16, 2020
Current and projected future economic burden of Parkinson's disease in the U.SWenya Yang, Jamie L Hamilton, Catherine Kopil, et al.
Pageof 21